Generics

A new study published in Pediatrics showed a decrease in prescription drug dispensing for children during the COVID-19 pandemic, including for infection-related medicines and chronic disease treatments.

High-dose buprenorphine therapy, provided under emergency department care, is safe and well-tolerated in patients with opioid use disorder, according to study results.

Acetaminophen injection, 1000 mg/100 mL, is an FDA-approved generic to Ofirmev.

Eighteen companies are working together to ensure equitable access to effective COVID-19 treatments for low- and middle-income countries

The new model will test a new way to lower increasing drug prices for patients paying for drugs under Medicare Part B.

Bill SB 852 would address the affordability and accessibility of generic drugs, including insulin and epinephrine, in California.

The generic pipeline continues to provide significant value to payers and patients as key products in top therapeutic classes lose patent protection.

Pharmacy organizations stress that government initiatives must include an overall plan for drug pricing, payment model, and supply chain transparency.

Why do we pharmacists buy generics from foreign manufacturers? The answer is pure and simple: the cost.

Mylan has launched the first FDA-approved generic version of Biogen’s dimethyl fumarate (Tecfidera) for relapsing forms of multiple sclerosis.

Pharmacists are in a unique position to recommend cost-saving generics and counsel patients on generic substitution.

The advent of generic and biosimilar medicines for novel treatments has helped bridge the gap in the delivery of cancer care between the United States and India, according to the study.

Sandoz is collaborating with Civica Rx to provide critical injectable generic medicines to hospitals to help reduce supply shortages.

Medicare beneficiary out-of-pocket costs for generic drugs used to treat chronic conditions declined from 2009 to 2017.

Check out this week's most important coronavirus-related news.

Demand for an affordable generic steroid soared after preliminary findings from a study showed it may be effective in reducing deaths from the coronavirus disease 2019 (COVID-19).

Survey respondents contradicted prior research that has suggested that manufacturer changes in medication appearance affect perceptions of safety and effectiveness.

The study’s authors examined the opportunity to decrease the overall cost of bortezomib by $300-400 million by switching patients to the generic version.

This year may mark a dramatic difference in the development and approval of complex generic drug products.

Dr. Reddy’s Laboratories has launched its ziprasidone mesylate 20 mg/mL for injection, the first generic version of Geodon (Pfizer) for injection. 

A pharmacy group is taking a wait-and-see approach after California Governor Gavin Newsom (D) announced several drug reforms–including a state generic prescription drug label.

What are some of the factors affecting whether a brand-name drug has generic competition?

Pharmacists can help advocate for availability and coverage.

Removing patient barriers to generic drugs.

Savings totaled $293 billion in 2018.

Abbreviated New Drug Applications, state laws, and more.

Biosimilars may need more time to devleop in the market.

Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.

New changes are making it more difficult for generics and biosimilars to compete on formularies.

First generic specialty injections approved for Novadoz Pharmaceuticals.